Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura

Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2002, Vol.41(12), pp.1199-1203
Hauptverfasser: KAMEI, Nozomu, YAMANE, Kiminori, YAMASHITA, Yasuyo, NAKANISHI, Shuhei, WATANABE, Hiroshi, FUJIKAWA, Rumi, HIYAMA, Keiko, ISHIOKA, Shinichi, MENDOZA, Giro, KOHNO, Nobuoki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1203
container_issue 12
container_start_page 1199
container_title Internal Medicine
container_volume 41
creator KAMEI, Nozomu
YAMANE, Kiminori
YAMASHITA, Yasuyo
NAKANISHI, Shuhei
WATANABE, Hiroshi
FUJIKAWA, Rumi
HIYAMA, Keiko
ISHIOKA, Shinichi
MENDOZA, Giro
KOHNO, Nobuoki
description Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose γ-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases. (Internal Medicine 41: 1199-1203, 2002)
doi_str_mv 10.2169/internalmedicine.41.1199
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72820220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72820220</sourcerecordid><originalsourceid>FETCH-LOGICAL-c616t-84d38e0141d0781d462ccc04a045e45611ab68e6a029ca55b408a5751db046b33</originalsourceid><addsrcrecordid>eNplkcFu1DAQhi0EokvhFZAvwCmL7ThOcqy6pVRUaqUtZ2vizLauEjvYzkp5AN6bpLu0Elz-Ocw3M7_mJ4RythZc1V-tSxgcdD221liHa8nXnNf1K7LiuayzUuTFa7JiNa8yMcsJeRfjI2N5VdbiLTnhohB83rQiv89cstmPkS618e2U3fpok90j3ZoOg28x9JBtFk2-n56akd7sMXQw0O3k2uB7pBvcY-cH6-7pZYA9xi90YyNCRAqupVd9Pzqkdw8z3HgzJT-gs4bejmEYA7wnb3bQRfxwrKfk57eLu_Pv2fXN5dX52XVmFFcpq2SbV8i45C0rK95KJYwxTAKTBcpCcQ6NqlABE7WBomgkq6AoC942TKomz0_J58PeIfhfI8akexsNdh049GPUpagEE4LNYHUATfAxBtzpIdgewqQ500sE-t8ItOR6iWAe_Xi8MTZz82Xw-PMZ-HQEIBrodgGcsfGFk4XMS7WY3R64x5jgHp8BCMnO0fznYD4unlz81cXOM20eIGh0-R8dR7Tr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72820220</pqid></control><display><type>article</type><title>Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>KAMEI, Nozomu ; YAMANE, Kiminori ; YAMASHITA, Yasuyo ; NAKANISHI, Shuhei ; WATANABE, Hiroshi ; FUJIKAWA, Rumi ; HIYAMA, Keiko ; ISHIOKA, Shinichi ; MENDOZA, Giro ; KOHNO, Nobuoki</creator><creatorcontrib>KAMEI, Nozomu ; YAMANE, Kiminori ; YAMASHITA, Yasuyo ; NAKANISHI, Shuhei ; WATANABE, Hiroshi ; FUJIKAWA, Rumi ; HIYAMA, Keiko ; ISHIOKA, Shinichi ; MENDOZA, Giro ; KOHNO, Nobuoki</creatorcontrib><description>Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose γ-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases. (Internal Medicine 41: 1199-1203, 2002)</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.41.1199</identifier><identifier>PMID: 12521216</identifier><language>eng</language><publisher>Tokyo: The Japanese Society of Internal Medicine</publisher><subject>Adult ; Anti-Inflammatory Agents - therapeutic use ; anti-thyroid drug ; Antigens, Nuclear - immunology ; Antithyroid Agents - therapeutic use ; Autoantibodies - blood ; Biological and medical sciences ; Dermatomyositis - complications ; Dermatomyositis - drug therapy ; Dermatomyositis - immunology ; DNA Helicases ; DNA-Binding Proteins - immunology ; Endocrinopathies ; Female ; Graves Disease - complications ; Graves Disease - drug therapy ; Graves Disease - immunology ; Humans ; Ku Autoantigen ; Medical sciences ; Methimazole - therapeutic use ; natural killer Tcell ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Platelet Transfusion ; Propylthiouracil - therapeutic use ; Purpura, Thrombocytopenic, Idiopathic - complications ; Purpura, Thrombocytopenic, Idiopathic - immunology ; Purpura, Thrombocytopenic, Idiopathic - therapy ; Scleroderma, Systemic - complications ; Scleroderma, Systemic - drug therapy ; Scleroderma, Systemic - immunology ; Steroids ; thrombocytopenia ; Thyroid. Thyroid axis (diseases)</subject><ispartof>Internal Medicine, 2002, Vol.41(12), pp.1199-1203</ispartof><rights>The Japanese Society of Internal Medicine</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c616t-84d38e0141d0781d462ccc04a045e45611ab68e6a029ca55b408a5751db046b33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14543763$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12521216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAMEI, Nozomu</creatorcontrib><creatorcontrib>YAMANE, Kiminori</creatorcontrib><creatorcontrib>YAMASHITA, Yasuyo</creatorcontrib><creatorcontrib>NAKANISHI, Shuhei</creatorcontrib><creatorcontrib>WATANABE, Hiroshi</creatorcontrib><creatorcontrib>FUJIKAWA, Rumi</creatorcontrib><creatorcontrib>HIYAMA, Keiko</creatorcontrib><creatorcontrib>ISHIOKA, Shinichi</creatorcontrib><creatorcontrib>MENDOZA, Giro</creatorcontrib><creatorcontrib>KOHNO, Nobuoki</creatorcontrib><title>Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose γ-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases. (Internal Medicine 41: 1199-1203, 2002)</description><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>anti-thyroid drug</subject><subject>Antigens, Nuclear - immunology</subject><subject>Antithyroid Agents - therapeutic use</subject><subject>Autoantibodies - blood</subject><subject>Biological and medical sciences</subject><subject>Dermatomyositis - complications</subject><subject>Dermatomyositis - drug therapy</subject><subject>Dermatomyositis - immunology</subject><subject>DNA Helicases</subject><subject>DNA-Binding Proteins - immunology</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Graves Disease - complications</subject><subject>Graves Disease - drug therapy</subject><subject>Graves Disease - immunology</subject><subject>Humans</subject><subject>Ku Autoantigen</subject><subject>Medical sciences</subject><subject>Methimazole - therapeutic use</subject><subject>natural killer Tcell</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Platelet Transfusion</subject><subject>Propylthiouracil - therapeutic use</subject><subject>Purpura, Thrombocytopenic, Idiopathic - complications</subject><subject>Purpura, Thrombocytopenic, Idiopathic - immunology</subject><subject>Purpura, Thrombocytopenic, Idiopathic - therapy</subject><subject>Scleroderma, Systemic - complications</subject><subject>Scleroderma, Systemic - drug therapy</subject><subject>Scleroderma, Systemic - immunology</subject><subject>Steroids</subject><subject>thrombocytopenia</subject><subject>Thyroid. Thyroid axis (diseases)</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkcFu1DAQhi0EokvhFZAvwCmL7ThOcqy6pVRUaqUtZ2vizLauEjvYzkp5AN6bpLu0Elz-Ocw3M7_mJ4RythZc1V-tSxgcdD221liHa8nXnNf1K7LiuayzUuTFa7JiNa8yMcsJeRfjI2N5VdbiLTnhohB83rQiv89cstmPkS618e2U3fpok90j3ZoOg28x9JBtFk2-n56akd7sMXQw0O3k2uB7pBvcY-cH6-7pZYA9xi90YyNCRAqupVd9Pzqkdw8z3HgzJT-gs4bejmEYA7wnb3bQRfxwrKfk57eLu_Pv2fXN5dX52XVmFFcpq2SbV8i45C0rK95KJYwxTAKTBcpCcQ6NqlABE7WBomgkq6AoC942TKomz0_J58PeIfhfI8akexsNdh049GPUpagEE4LNYHUATfAxBtzpIdgewqQ500sE-t8ItOR6iWAe_Xi8MTZz82Xw-PMZ-HQEIBrodgGcsfGFk4XMS7WY3R64x5jgHp8BCMnO0fznYD4unlz81cXOM20eIGh0-R8dR7Tr</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>KAMEI, Nozomu</creator><creator>YAMANE, Kiminori</creator><creator>YAMASHITA, Yasuyo</creator><creator>NAKANISHI, Shuhei</creator><creator>WATANABE, Hiroshi</creator><creator>FUJIKAWA, Rumi</creator><creator>HIYAMA, Keiko</creator><creator>ISHIOKA, Shinichi</creator><creator>MENDOZA, Giro</creator><creator>KOHNO, Nobuoki</creator><general>The Japanese Society of Internal Medicine</general><general>Japanese Society of Internal Medicine</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021201</creationdate><title>Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura</title><author>KAMEI, Nozomu ; YAMANE, Kiminori ; YAMASHITA, Yasuyo ; NAKANISHI, Shuhei ; WATANABE, Hiroshi ; FUJIKAWA, Rumi ; HIYAMA, Keiko ; ISHIOKA, Shinichi ; MENDOZA, Giro ; KOHNO, Nobuoki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c616t-84d38e0141d0781d462ccc04a045e45611ab68e6a029ca55b408a5751db046b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>anti-thyroid drug</topic><topic>Antigens, Nuclear - immunology</topic><topic>Antithyroid Agents - therapeutic use</topic><topic>Autoantibodies - blood</topic><topic>Biological and medical sciences</topic><topic>Dermatomyositis - complications</topic><topic>Dermatomyositis - drug therapy</topic><topic>Dermatomyositis - immunology</topic><topic>DNA Helicases</topic><topic>DNA-Binding Proteins - immunology</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Graves Disease - complications</topic><topic>Graves Disease - drug therapy</topic><topic>Graves Disease - immunology</topic><topic>Humans</topic><topic>Ku Autoantigen</topic><topic>Medical sciences</topic><topic>Methimazole - therapeutic use</topic><topic>natural killer Tcell</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Platelet Transfusion</topic><topic>Propylthiouracil - therapeutic use</topic><topic>Purpura, Thrombocytopenic, Idiopathic - complications</topic><topic>Purpura, Thrombocytopenic, Idiopathic - immunology</topic><topic>Purpura, Thrombocytopenic, Idiopathic - therapy</topic><topic>Scleroderma, Systemic - complications</topic><topic>Scleroderma, Systemic - drug therapy</topic><topic>Scleroderma, Systemic - immunology</topic><topic>Steroids</topic><topic>thrombocytopenia</topic><topic>Thyroid. Thyroid axis (diseases)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAMEI, Nozomu</creatorcontrib><creatorcontrib>YAMANE, Kiminori</creatorcontrib><creatorcontrib>YAMASHITA, Yasuyo</creatorcontrib><creatorcontrib>NAKANISHI, Shuhei</creatorcontrib><creatorcontrib>WATANABE, Hiroshi</creatorcontrib><creatorcontrib>FUJIKAWA, Rumi</creatorcontrib><creatorcontrib>HIYAMA, Keiko</creatorcontrib><creatorcontrib>ISHIOKA, Shinichi</creatorcontrib><creatorcontrib>MENDOZA, Giro</creatorcontrib><creatorcontrib>KOHNO, Nobuoki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAMEI, Nozomu</au><au>YAMANE, Kiminori</au><au>YAMASHITA, Yasuyo</au><au>NAKANISHI, Shuhei</au><au>WATANABE, Hiroshi</au><au>FUJIKAWA, Rumi</au><au>HIYAMA, Keiko</au><au>ISHIOKA, Shinichi</au><au>MENDOZA, Giro</au><au>KOHNO, Nobuoki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>41</volume><issue>12</issue><spage>1199</spage><epage>1203</epage><pages>1199-1203</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose γ-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases. (Internal Medicine 41: 1199-1203, 2002)</abstract><cop>Tokyo</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>12521216</pmid><doi>10.2169/internalmedicine.41.1199</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2002, Vol.41(12), pp.1199-1203
issn 0918-2918
1349-7235
language eng
recordid cdi_proquest_miscellaneous_72820220
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Anti-Inflammatory Agents - therapeutic use
anti-thyroid drug
Antigens, Nuclear - immunology
Antithyroid Agents - therapeutic use
Autoantibodies - blood
Biological and medical sciences
Dermatomyositis - complications
Dermatomyositis - drug therapy
Dermatomyositis - immunology
DNA Helicases
DNA-Binding Proteins - immunology
Endocrinopathies
Female
Graves Disease - complications
Graves Disease - drug therapy
Graves Disease - immunology
Humans
Ku Autoantigen
Medical sciences
Methimazole - therapeutic use
natural killer Tcell
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Platelet Transfusion
Propylthiouracil - therapeutic use
Purpura, Thrombocytopenic, Idiopathic - complications
Purpura, Thrombocytopenic, Idiopathic - immunology
Purpura, Thrombocytopenic, Idiopathic - therapy
Scleroderma, Systemic - complications
Scleroderma, Systemic - drug therapy
Scleroderma, Systemic - immunology
Steroids
thrombocytopenia
Thyroid. Thyroid axis (diseases)
title Anti-Ku Antibody-Positive Scleroderma-Dermatomyositis Overlap Syndrome Developing Graves' Disease and Immune Thrombocytopenic Purpura
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T09%3A25%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Ku%20Antibody-Positive%20Scleroderma-Dermatomyositis%20Overlap%20Syndrome%20Developing%20Graves'%20Disease%20and%20Immune%20Thrombocytopenic%20Purpura&rft.jtitle=Internal%20Medicine&rft.au=KAMEI,%20Nozomu&rft.date=2002-12-01&rft.volume=41&rft.issue=12&rft.spage=1199&rft.epage=1203&rft.pages=1199-1203&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.41.1199&rft_dat=%3Cproquest_cross%3E72820220%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72820220&rft_id=info:pmid/12521216&rfr_iscdi=true